Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATTOTCMKTS:FCITNYSE:SDRNYSE:STJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/AFCITFirst Citrus Bancorporation$47.82$47.82$25.00▼$50.00N/AN/A1,382 shsN/ASDRSandRidge Mississippian Trust II$0.13$0.20▼$1.12$6.37M1.14172,872 shs434,700 shsSTJSt Jude Medical$80.82$0.00$48.83▼$84.00N/AN/A8.54 million shsN/A10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%FCITFirst Citrus Bancorporation0.00%0.00%0.00%0.00%0.00%SDRSandRidge Mississippian Trust II0.00%0.00%0.00%0.00%0.00%STJSt Jude Medical0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AFCITFirst Citrus BancorporationN/AN/AN/AN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust IIN/AN/AN/AN/AN/AN/AN/AN/ASTJSt Jude MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/AFCITFirst Citrus Bancorporation 0.00N/AN/AN/ASDRSandRidge Mississippian Trust II 0.00N/AN/AN/ASTJSt Jude Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AFCITFirst Citrus BancorporationN/AN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$14.64M0.00N/A1.11$0.85 per share0.00STJSt Jude MedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/AFCITFirst Citrus BancorporationN/AN/A0.00∞N/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$10.32MN/A1.28N/AN/A66.85%21.99%21.99%N/ASTJSt Jude MedicalN/A$5.8713.77∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/AFCITFirst Citrus BancorporationN/AN/AN/AN/AN/ASDRSandRidge Mississippian Trust II$0.0522.12%N/AN/AN/ASTJSt Jude Medical$1.241.53%N/A21.12%N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/AFCITFirst Citrus BancorporationN/ASDRSandRidge Mississippian Trust II0.98%STJSt Jude Medical82.73%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/AFCITFirst Citrus BancorporationN/ASDRSandRidge Mississippian Trust IIN/ASTJSt Jude Medical4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableFCITFirst Citrus BancorporationN/AN/AN/ANot OptionableSDRSandRidge Mississippian Trust IIN/A49.73 millionN/AOptionableSTJSt Jude MedicalN/AN/AN/AOptionableATT, STJ, SDR, and FCIT HeadlinesRecent News About These CompaniesSt. Jude begins interior buildout of new 15-story outpatient clinic buildingMay 28 at 3:31 AM | bizjournals.com'It's just amazing what they do': St. Jude treats the entire family, not just the patientMay 21, 2025 | msn.comHow St. Jude’s medical social workers help parents navigate child’s diagnosisMay 15, 2025 | msn.comFamily shares experience at St. Jude Children’s Research HospitalMay 10, 2025 | wbko.comFighting Sickle Cell: How St. Jude and Donors Gave Avery a New Lease on LifeApril 29, 2025 | msn.comOne Step at a Time: How St. Jude and Supporters Helped Arielle Walk AgainApril 29, 2025 | msn.comSt. Jude Rock and Roll Music City marathon marks 25th anniversary this weekendApril 26, 2025 | newschannel5.comTopeka Dream Home helps St. Jude patients across the U.S.April 24, 2025 | msn.comLocal companies donate materials, labor for St. Jude Dream Home GivewayMarch 28, 2025 | msn.comA St. Jude superhero—this doctor has dedicated her life to treating cancer patientsMarch 22, 2025 | msn.comLocal representative fighting for St. Jude medical care in CharlestonMarch 18, 2025 | msn.com'St. Jude for pets': Decatur vet launching nonprofit research hospital to study diseases affecting humans and animalsMarch 12, 2025 | msn.comSt. Jude, UT, Vanderbilt push to keep NIH fundingFebruary 20, 2025 | dailymemphian.comProposed federal-funding cuts could come at a cost for St. Jude, UTHSCFebruary 12, 2025 | dailymemphian.comCould NIH funding cut affect St. Jude Children's Research Hospital? Here's what we knowFebruary 11, 2025 | msn.comNIH cuts could hurt research at St. Jude, UTFebruary 11, 2025 | msn.comSt. Jude creates new leadership roleJanuary 24, 2025 | beckershospitalreview.comEvidence still under review for suspects in 2023 shooting death of St. Jude doctorJanuary 16, 2025 | wreg.comOklahoma Family Bakes For A Cause To Help St. Jude Children's HospitalDecember 24, 2024 | newson6.comSt. Jude names executive vice president and chief administrative officerDecember 11, 2024 | msn.comTop HeadlinesView All HeadlinesAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in Value3 High-Paying Dividend Stocks That Still Have Safe PayoutsBy Chris Markoch | May 27, 2025View 3 High-Paying Dividend Stocks That Still Have Safe Payouts3 High-Yield Dividend Stocks That Could Rally Near 52-Week LowsBy Chris Markoch | May 1, 2025View 3 High-Yield Dividend Stocks That Could Rally Near 52-Week LowsAT&T, Verizon & T-Mobile: Who Won the Big 3 Telecom Battle in Q1?By Leo Miller | May 1, 2025View AT&T, Verizon & T-Mobile: Who Won the Big 3 Telecom Battle in Q1?Nextracker’s Solar Surge: Will It Shatter Its All-Time High?By Thomas Hughes | May 18, 2025View Nextracker’s Solar Surge: Will It Shatter Its All-Time High?ATT, STJ, SDR, and FCIT Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.First Citrus Bancorporation OTCMKTS:FCIT$47.82 0.00 (0.00%) As of 01/13/2023As of January 3, 2023, First Citrus Bancorporation, Inc. was acquired by DFCU Financial. First Citrus Bank, a $670 million commercial bank, was established in 1999 and is headquartered in Tampa. Ranked as one of the Top 100 Community Banks in 2021 by American Banker and named Top 5 SBA Lender in Tampa Bay for 2020 by the SBA. First Citrus Bank was selected as the Tampa Bay Chamber of Commerce 2019 Small Business of the Year and ranked as one of the Top 25 Commercial Loan Producers in the Nation by the magazine Independent Banker. It serves businesses and individuals through a range of tailored financial solutions specializing in personal and business banking services with six locations throughout Tampa Bay. First Citrus Bank enhances vibrancy throughout Tampa Bay by helping families become more financially secure and businesses economically successful. For additional information, please visit http://www.firstcitrus.com.SandRidge Mississippian Trust II NYSE:SDRSandRidge Mississippian Trust II holds royalty interests in oil and natural gas properties. The company's properties are located in the Mississippian formation in Alfalfa, Grant, Kay, Noble, and Woods counties in northern Oklahoma and Barber; and Comanche, Harper, and Sumner counties in southern Kansas. As of December 31, 2018, its properties consisted of royalty interests in the initial wells and 173 additional wells. The company was founded in 2011 and is based in Houston, Texas.St Jude Medical NYSE:STJSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
